Company Filing History:
Years Active: 2025
Title: Yilong Yang: Innovator in mRNA Vaccine Development
Introduction
Yilong Yang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of vaccine development, particularly in the area of mRNA technology. His innovative work focuses on creating effective vaccines against infectious diseases.
Latest Patents
Yilong Yang holds a patent for an mRNA vaccine encoding a fusion antigen against Mpox and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This mRNA molecule contains polynucleotides encoding the M1R antigen of Mpox, the RBD antigen of SARS-CoV-2, and the A35R antigen of Mpox. The application of this mRNA molecule in vaccine preparation demonstrates its potential to induce considerable neutralizing antibody responses against both Mpox and SARS-CoV-2. Notably, this vaccine provides 100% immune protection against the lethal challenge of ectromelia virus. The innovative approach of synthesizing a single mRNA molecule and encapsulating it within lipid nanoparticles offers a wider application prospect compared to traditional multivalent mRNA vaccine compositions.
Career Highlights
Yilong Yang is affiliated with the Academy of Military Medical Sciences, where he conducts research and development in vaccine technology. His work has garnered attention for its potential impact on public health and disease prevention.
Collaborations
Yilong Yang collaborates with notable colleagues, including Wei Chen and Junjie Xu, who contribute to his research efforts and advancements in vaccine development.
Conclusion
Yilong Yang's innovative contributions to mRNA vaccine technology highlight his role as a key inventor in the fight against infectious diseases. His work not only advances scientific knowledge but also has the potential to save lives through effective vaccination strategies.